𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oxidative polymorphism of debrisoquine is not related to human colo-rectal cancer

✍ Scribed by J. M. Ladero; J. Benítez; J. F. González; E. Vargas; M. Díaz-Rubio


Publisher
Springer
Year
1991
Tongue
English
Weight
343 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


The oxidative polymorphism of debrisoquine (DBQ) has been determined in 89 patients with colo-rectal cancer and in 556 normal control subjects. Four patients and 34 controls, with a metabolic ratio greater than 12.6, were classified as poor metabolisers of DBQ (n.s.). No difference was found in the distribution of the frequencies of the MR of DBQ between patients and controls. It is concluded that polymorphic oxidation of DBQ is not related to the risk of developing colo-rectal cancer in human beings.


📜 SIMILAR VOLUMES


p53 gene mutation is not directly relate
✍ Ichikawa, Daisuke; Yamaguchi, Toshiharu; Shirasu, Morio; Kitamura, Kazuya; Inaza 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 2 views

Background: Several studies have recently demonstrated that apoptosis of cancer cells is triggered by diverse adjuvant cancer therapies and the induction of apoptosis correlates with the sensitivity of the primary tumor to such therapies. Methods: We investigated the factors modulating adjuvant can

Sensitivity to cis-diamminedichloroplati
✍ Hilmar M. Warenius; Laurence A. Seabra; Paula Maw 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

Although several oncogenes, including c-myc, ras and c-raf-I, have been implicated in cellular resistance to ionising radiation, there is less information relating oncogene expression to cisdiamminedochloroplatinum (CDDP) resistance. However, transfection of c-myc or v-H-ras and activation of protei